Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
CAS Number:
[945721-28-8]
* VAT and and shipping costs not included. Errors and price changes excepted
